PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
73.67%
G&A change of 73.67% versus flat Healthcare overhead. Walter Schloss would verify efficiency.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
73.67%
Operating expenses change of 73.67% versus flat Healthcare costs. Walter Schloss would verify control.
73.67%
Total costs change of 73.67% versus flat Healthcare costs. Walter Schloss would verify control.
5.36%
Interest expense change of 5.36% versus flat Healthcare costs. Walter Schloss would verify control.
No Data
No Data available this quarter, please select a different quarter.
-73.67%
EBITDA decline while Healthcare median is -0.42%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
-73.67%
Operating income decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
5.36%
Other expenses change of 5.36% versus flat Healthcare. Walter Schloss would verify control.
-89.61%
Pre-tax income decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-89.61%
Net income decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
-90.91%
EPS decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-90.91%
Diluted EPS decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.